NDC 43598-0541-25

Pegylated liposomal doxorubicin injection at Lancaster General Health

AI-generated description

How this description was generated

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

DOXORUBICIN HCL LIPOSOMAL 2 MG/ML IV SUSP

Lancaster, PA

See all hospitals reporting NDC 43598-0541-25 →

Pricing by billing methodology

Price type

How this price compares nationally

Lancaster General Health’s median price of $1.1k is 3% above the median hospital's median price ($1.1k), higher than 51% of the 207 hospitals reporting NDC 43598-0541-25. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Mar 31, 2026

Compare to other hospitals

See Pegylated liposomal doxorubicin injection pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.